Sort   by:  
 Page size 
UnknownPB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments.
Not available
S-EPMC2857135 | biostudies-literature
UnknownProtocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
Not available
S-EPMC7507250 | biostudies-literature
UnknownGenome Sequencing for Genetics Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study.
Not available
S-EPMC8845475 | biostudies-literature
UnknownDiuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation.
Not available
S-EPMC10567662 | biostudies-literature
UnknownFinal results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
Not available
S-EPMC9132543 | biostudies-literature
UnknownAcute myocarditis according to age: Presentation, management and early outcomes.
Not available
S-EPMC12287872 | biostudies-literature
UnknownThe Economic, Medical and Psychosocial Consequences of Whole Genome Sequencing for the Genetic Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study Protocol.
Not available
S-EPMC9013934 | biostudies-literature
UnknownRemdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Not available
S-EPMC8439621 | biostudies-literature
UnknownAn open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Not available
S-EPMC8149166 | biostudies-literature
UnknownCardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
Not available
S-EPMC11327784 | biostudies-literature
Sort   by:  
 Page size